127 related articles for article (PubMed ID: 8945780)
1. Characterization of sodium hypochlorite degradation of beta-glucan in relation to its metabolism in vivo.
Miura NN; Ohno N; Adachi Y; Yadomae T
Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2137-41. PubMed ID: 8945780
[TBL] [Abstract][Full Text] [Related]
2. Gradual solubilization of Candida cell wall beta-glucan by oxidative degradation in mice.
Miura NN; Miura T; Ohno N; Adachi Y; Watanabe M; Tamura H; Tanaka S; Yadomae T
FEMS Immunol Med Microbiol; 1998 Jun; 21(2):123-9. PubMed ID: 9685001
[TBL] [Abstract][Full Text] [Related]
3. Preparation and properties of metabolically 3H- or 13C-labeled (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
Suda M; Ohno N; Adachi Y; Yadomae T
Carbohydr Res; 1994 Feb; 254():213-9. PubMed ID: 8180985
[TBL] [Abstract][Full Text] [Related]
4. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice.
Suda M; Ohno N; Hashimoto T; Koizumi K; Adachi Y; Yadomae T
FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):93-100. PubMed ID: 8880133
[TBL] [Abstract][Full Text] [Related]
5. Metabolic 13C-labeling of an antitumor (1-->3)-beta-D-glucan, SSG, from Sclerotinia sclerotiorum IFO 9395.
Suda M; Ohno N; Adachi Y; Yadomae T
Biosci Biotechnol Biochem; 1995 Feb; 59(2):203-7. PubMed ID: 7766018
[TBL] [Abstract][Full Text] [Related]
6. Solubilization of yeast cell-wall beta-(1-->3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction.
Ohno N; Uchiyama M; Tsuzuki A; Tokunaka K; Miura NN; Adachi Y; Aizawa MW; Tamura H; Tanaka S; Yadomae T
Carbohydr Res; 1999 Mar; 316(1-4):161-72. PubMed ID: 10420595
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395.
Ohno N; Kurachi K; Yadomae T
J Pharmacobiodyn; 1987 Sep; 10(9):478-86. PubMed ID: 3437391
[TBL] [Abstract][Full Text] [Related]
8. Preparation and antitumor activity of hydroxyethylated derivatives of 6-branched (1----3)-beta-D-glucan, SSG, obtained from the culture filtrate of Sclerotinia sclerotiorum IFO 9395.
Kurachi K; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2527-31. PubMed ID: 2285987
[TBL] [Abstract][Full Text] [Related]
9. Reactivity of Limulus amoebocyte lysate towards (1----3)-beta-D-glucans.
Ohno N; Emori Y; Yadomae T; Saito K; Masuda A; Oikawa S
Carbohydr Res; 1990 Oct; 207(2):311-8. PubMed ID: 2076521
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity and structural characterization of a (1----3)-beta-D-glucan extracted with cold alkali from sclerotia of Sclerotinia sclerotiorum IFO 9395.
Shinohara H; Ohno N; Yadomae T
Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):819-23. PubMed ID: 3409388
[No Abstract] [Full Text] [Related]
11. Inhibitory effect of beta-glucans on zymosan-mediated hydrogen peroxide production by murine peritoneal macrophages in vitro.
Adachi Y; Ohno N; Yadomae T
Biol Pharm Bull; 1993 May; 16(5):462-7. PubMed ID: 8364492
[TBL] [Abstract][Full Text] [Related]
12. Two different conformations of the antitumor beta-D-glucan produced by Sclerotinia sclerotiorum IFO 9395.
Ohno N; Yadomae T
Carbohydr Res; 1987 Feb; 159(2):293-302. PubMed ID: 3567988
[TBL] [Abstract][Full Text] [Related]
13. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146
[TBL] [Abstract][Full Text] [Related]
14. The effects of a highly branched beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic tumors in mice.
Suzuki I; Hashimoto K; Yadomae T
J Pharmacobiodyn; 1988 Aug; 11(8):527-32. PubMed ID: 3236210
[TBL] [Abstract][Full Text] [Related]
15. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation.
Sakurai T; Ohno N; Suzuki I; Yadomae T
Immunopharmacology; 1995 Aug; 30(2):157-66. PubMed ID: 8530257
[TBL] [Abstract][Full Text] [Related]
16. Effect of intraperitoneally administered beta-1,3-glucan, SSG, obtained from Sclerotinia sclerotiorum IFO 9395 on the functions of murine alveolar macrophages.
Sakurai T; Suzuki I; Kinoshita A; Oikawa S; Masuda A; Ohsawa M; Yadomae T
Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):214-7. PubMed ID: 2049804
[TBL] [Abstract][Full Text] [Related]
17. Different role of serum components and cytokines on alveolar macrophage activation by soluble fungal (1-->3)-beta-D-glucan.
Sakurai T; Kaise T; Yadomae T; Matsubara C
Eur J Pharmacol; 1997 Sep; 334(2-3):255-63. PubMed ID: 9369356
[TBL] [Abstract][Full Text] [Related]
18. Relationship between the physical properties of Candida albicans cell well beta-glucan and activation of leukocytes in vitro.
Ishibashi K; Miura NN; Adachi Y; Ogura N; Tamura H; Tanaka S; Ohno N
Int Immunopharmacol; 2002 Jul; 2(8):1109-22. PubMed ID: 12349948
[TBL] [Abstract][Full Text] [Related]
19. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice.
Suda M; Ohno N; Adachi Y; Yadomae T
J Pharmacobiodyn; 1992 Aug; 15(8):417-26. PubMed ID: 1479542
[TBL] [Abstract][Full Text] [Related]
20. The oxidative degradation of barley β-glucan in the presence of ascorbic acid or hydrogen peroxide.
Mäkelä N; Sontag-Strohm T; Maina NH
Carbohydr Polym; 2015 Jun; 123():390-5. PubMed ID: 25843872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
